Clinical trials
Terminated Phase 3 Dyslipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2003 | 4 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 4 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Takeda | 7 |
| Merck Sharp & Dohme LLC | 4 |
| Pfizer | 2 |
| Sanofi | 2 |
| Amgen | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
| Institut de Recherches Internationales Servier | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Karo Bio AB | 1 |
| Kowa Research Institute, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 23 |
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 7 |
| Glucose Metabolism Disorders | 7 |
| Diabetes Mellitus, Lipoatrophic | 6 |
| Hypercholesterolemia | 5 |
| Hyperlipidemias | 4 |
| Obesity | 3 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.